Arctic Asset Management
Established in 2016 as part of Arctic Asset Management, the Arctic Life Science team manages two global UCITS funds - Arctic Aurora LifeScience and Arctic Aurora Biotech Select - focusing on investments in the global healthcare sector. These funds provide exposure to leading innovations in medical science through risk-managed equity portfolios, primarily in the biopharmaceutical sector. Arctic Aurora LifeScience invests in mid- and late-stage biotechnology companies as well as large pharmaceutical companies, while Arctic Aurora Biotech Select invests in both larger and smaller biotechnology companies, including some earlier-stage companies, offering greater upside potential with slightly higher risk. The team consists of experienced specialists with extensive knowledge of biotechnology and pharmacology, covering both US and European markets. Both strategies are available as UCITS funds.
DRZ
DRZ is a 100% employee owned, active institutional investment manager committed to generating long-term value through a unique stock-selection process combining dividend yield, relative valuation, and fundamental catalysts. Since 1995, DRZ have consistently implemented their Value methodology on behalf of their institutional clients across the firm’s equity strategies. As of December 2023, DRZ’s EM Value strategy is available as a UCITS fund.
Eagle Capital Management
Eagle Capital Management was founded in 1988 and has specialised in managing a U.S. large-cap, value strategy using the same philosophy and process since inception. The Eagle strategy follows a fundamental, low-turnover, research-driven approach that seeks to build a concentrated portfolio of 25‐35 undervalued positions, where near-term price distortions cloud the long-term appreciation opportunity. A key tenet of Eagle’s philosophy is to use the essence of time to one’s investment advantage – Time Arbitrage. Eagle has over $28.3bn in assets and offers the strategy in a UCITS vehicle.
Granahan Investment Management
Granahan (“GIM”) is a Boston-based small cap equity specialist founded in 1985. As a long-only fund manager, the firm has a focus on U.S. small cap companies with expansive growth potential. GIM utilises disciplined processes and proven tools to provide its clients consistent long-term performance across several distinct products. Firm-wide assets under management (“AUM”) are currently $2.4bn (as at September 2020) representing large institutions, family offices, and sub-advisory relationships across the globe. Granahan has several UCITS compliant funds.
Shikhara Investment Management
Shikhara Investment Management is an employee-owned investment management firm founded in 2023, specializing in Asia and India equity markets. With over 125 years of combined investing experience across Asian markets, Shikhara’s seasoned, multicultural team operates across Hong Kong, Mumbai, and New York. Their emerging markets heritage and local perspective provides unique insight into potential investment opportunities, enabling them to navigate uncertainty in rapidly evolving and inefficient markets while maintaining a long-term strategic view. Shikhara’s Asia ex-Japan strategy and India strategy are expected to launch as UCITS funds in 2025.
